- Grants since 2016
- 611
- Awarded, last 5 years (where amounts are published)
- €94.6M
- Funded works, last 5 years
- 5 837
- Funded works, all time
- 8 569
Grants
2025–2027 · grant
Development of Artificial Intelligence-powered prediction models of disease progression in facioscapulohumeral muscular dystrophy: DEAL-FSHD
Mauro Monforte · Agostino Gemelli University Polyclinic
2025–2027 · grant
Deciphering the role of the immune system in Wolfram Syndrome type 1
Maria Teresa Pallotta · University of Perugia
2025–2026 · grant
A microfluidic approach to reassess therapeutic strategies for vascular Ehlers-Danlos syndrome from an endothelial perspective – a proof of concept
Alessandro Fantin · University of Milan
2025–2028 · grant
Characterization of the natural history of Italian LAMA2-RD patients and identification of novel disease biomarkers
Alberto Zambon · Vita-Salute San Raffaele University
2025–2027 · grant
AAV-mediated overexpression of wild-type DSG2 as a strategy to contrast Arrhythmogenic (Right Ventricular) Cardiomyopathy
Martina Calore · University of Padua
2025–2027 · grant
Preclinical Development of Brain-Penetrant Compounds Halting Prion Neurotoxicity
Emiliano Biasini · University of Trento
2025–2027 · grant
Investigating Cx32 hemichannel dysfunction in Schwann cells: a potential therapeutic target for the X-linked form of Charcot-Marie-Tooth.
Mario Bortolozzi · Fondazione Per La Ricerca Biomedica Avanzata Onlus - Istituto Veneto Di Medicina Molecolare (vimm)
2025–2026 · grant
Preclinical evaluation of the therapeutic potential of Prime Editing in the RETT mouse model harboring the frequent MECP2 p.R168X mutation
Dario Balestra · University of Ferrara
2025–2027 · grant
Pharmacological stimulation of mitochondrial metabolism as a therapeutic approach in a mouse model of AHDS
Emanuela Bottani · University of Verona
2025–2028 · grant
Natural history and biomarkers in Facioscapolo-Humeral Muscular Dystrophy
Massimiliano Filosto · Centro Clinico Nemo
2025–2027 · grant
Target Identification and Evaluation of Risk in CPVT2 (TIER-CPVT2)
Chiara Marabelli · Fondazione Salvatore Maugeri
2025–2026 · grant
Human IPSC Technology to Investigate underlying mechanisms and potential therapeutic targets of Non-Syndromic XLID due to NEXMIF Gene Mutation
Laura Cancedda · Italian Institute of Technology
2025–2028 · grant
Developmental Trajectories in ARID1B-Related Disorder – a Multi-Method Multi-Site Prospective Natural History Study
Gaetano Cantalupo · University of Verona
2025–2027 · grant
Investigating a VPS13D-mediated mitophagic process to advance our understanding of the complex VPS13D-linked movement disorder(s).
Marianna Leonzino · National Research Council
2025–2026 · grant
Towards in vivo gene therapy for methylmalonic-acidemia with homocystinuria
Alessio Cantore · Vita-Salute San Raffaele University
2025–2026 · grant
Drug repurposing in vascular Ehlers-Danlos syndrome by using multi-OMIC signatures in human fibroblasts
Marco Castori · Irccs Casa Sollievo Della Sofferenza - Opera Padre Pio
2025–2027 · grant
Accelerating Therapies for GLUT1 Deficiency Syndrome with Small Molecule candidates
Marco Gaetano Lolicato · University of Pavia
2025–2026 · grant
Natural history in ambulant and non ambulant boys and young adults with Duchenne muscular dystrophy
Eugenio Maria Mercuri · Agostino Gemelli University Polyclinic
2025–2027 · grant
Better together: a Multi-model Approach for Pitt-Hopkins syndrome
Michela Ori · University of Pisa
2025–2027 · grant
Investigating mitochondrial alterations as novel therapeutic targets for the Aicardi-Goutières Syndrome
Anna Christina Kajaste-Rudnitski · University of Pavia
2025–2027 · grant
rational design of inhibitors of gelsolin amyloid aggregation
Matteo De Rosa · National Research Council
2025–2027 · grant
Uncover of molecular mechanism underlying neuroprotective effects of PEDF peptides as therapeutic agents for inherited retinal degeneration
Valeria Marigo · Università Degli Studi Di Modena E Reggio Emilia Unimore
2025–2026 · grant
Investigating the Therapeutic Potential of UDP-Glucuronic Acid Supplementation in Mouse Brain Organoids Modeling Jamuar Syndrome
Emanuela Bottani · University of Verona
2025–2027 · grant
Interaction of TBC1D24 with v-ATPase: pathophysiological mechanisms and novel therapeutic targets for rare TBC1D24 diseases
Anna Fassio · University of Genoa
2025–2027 · grant
Investigating the role of parvalbumin positive interneurons in PCDH19-related Developmental and epileptic encephalopathy-9 (DEE9)
Maria Passafaro · National Research Council
2025–2027 · grant
Gut-Lung axis in Cystic Fibrosis: pathophysiological basis for diagnostic and therapeutic approaches
Alessandra Bragonzi · Vita-Salute San Raffaele University
2025–2027 · grant
Analysis of genome function recovery upon pharmacological treatment in Hutchinson-Gilford Progeria Syndrome
Chiara Lanzuolo · Istituto Nazionale Genetica Molecolare
2025–2026 · grant
Engineering Nanocarriers for the Treatment of Allan-Herndon-Dudley Syndrome: Overcoming MCT8 Transport Deficiency
Alessandro Arcovito · Università Cattolica del Sacro Cuore
2025–2027 · grant
The Impact of SLC7A7 Deficiency on Macrophage Differentiation and Function in Lysinuric Protein Intolerance: Implications for Unraveling Disease Mechanisms and Developing New Therapeutic Strategies
Giusi Prencipe · Ospedale Pediatrico Bambino Gesù - Irccs
2025–2027 · grant
Unveiling the Neurobehavioral Implications of Inborn Error of Immunity Disorders: A Focus on WHIM Syndrome.
Simona Lodato · Humanitas University
2025–2027 · grant
Exploring the Role of SPP1 in Macrophage-Osteogenic Cell Crosstalk and its involvement in Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva
Silvia Brunelli · University of Milano-Bicocca
2025–2027 · grant
Why does impaired protein degradation lead to neuronal hyperexcitability and disturbed cortical functions?
Gian Michele Ratto · National Research Council
2025–2027 · grant
The evolutionary conserved circHTT(2,3,4,5,6) as a new disease modifier in Huntington's Disease pathology
Marta Biagioli · University of Trento
2025–2027 · grant
Heterochromatin compartment remodeling in Autosomal Dominant adult-onset demyelinating LeukoDystrophy - ADLD
Francesco Ferrari · Ifom Ets - Istituto Fondazione Di Oncologia Molecolare
2025–2027 · grant
Structure-activity relationship studies of Zn(II)-BnPyP for the development of dual anti-prion drugs
Chiara Zucchelli · Vita-Salute San Raffaele University
2025–2027 · grant
Development of new gene editing delivery systems that cross the blood brain barrier for the treatment of Krabbe Disease and other lysosomal storage disorders
Alessia Cavazza · Università Degli Studi Di Modena E Reggio Emilia Unimore
2025–2026 · grant
Dissecting the functional interaction between Scn1a and Scn3a genes in a therapeutic perspective for Dravet Syndrome
Gaia Colasante · Vita-Salute San Raffaele University
2025–2027 · grant
Insight neuropathic pain in Fabry disease:prokineticin system and neuroinflammation as novel therapeutic targets
Paola Sacerdote · University of Milan
2025–2027 · grant
Investigation of novel accessory proteins of neuronal endosomal CLC-3 and CLC-4 antiporters involved in neurodevelopmental disorders
Michael Pusch · National Research Council
2025–2026 · grant
Dissecting and reverting alterations in synaptic nanoarchitecture in SATB2-associated syndrome
Eugenio Fornasiero · University of Trieste